Another essential gene to consider is CTLA-4, which has been linked to the development of pulmonary and cutaneous sarcoidosis in patients treated with anti-CTLA-4 and anti-PD-L1 therapies for metastatic melanoma [96, 97]. Here, CTLA4 is linked to metastatic melanoma.